This compound is a protected amino acid derivative commonly employed as a peptide building block in solid-phase peptide synthesis. It features a fluorenylmethoxycarbonyl (Fmoc) protecting group and a methyl ether substituent on the threonine side chain, facilitating the construction of modified peptide sequences.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 928063-81-4
Fmoc-L-valine
Peptide synthesis intermediate
(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-methylbutanoic acid
Peptide synthesis building block
(2R,3S)-3-(tert-butoxy)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)butanoic acid
Peptide synthesis building block
N-((9H-Fluoren-9-ylmethoxy)carbonyl)-O-isopropyl-L-threonine
Fmoc-protected amino acid reagent
Z-Phg-OH
Peptide building block
1-(3,5-Dichlorophenyl)propan-1-one
Pharmaceutical intermediate for midazolam impurities
4-(4-Fluorobenzyl)piperidine hydrochloride
pharmaceutical intermediate
7-benzyloxyindole-3-carbaldehyde
Pharmaceutical intermediate
(2S,3R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methoxybutanoic acid
BOGQZFFOTLSMMA-XIKOKIGWSA-N
C[C@H]([C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)OC